Maneesha Mehra

1.4k total citations
37 papers, 985 citations indexed

About

Maneesha Mehra is a scholar working on Oncology, Hematology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Maneesha Mehra has authored 37 papers receiving a total of 985 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 14 papers in Hematology and 12 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Maneesha Mehra's work include Prostate Cancer Treatment and Research (12 papers), Multiple Myeloma Research and Treatments (11 papers) and Prostate Cancer Diagnosis and Treatment (7 papers). Maneesha Mehra is often cited by papers focused on Prostate Cancer Treatment and Research (12 papers), Multiple Myeloma Research and Treatments (11 papers) and Prostate Cancer Diagnosis and Treatment (7 papers). Maneesha Mehra collaborates with scholars based in United States, Belgium and United Kingdom. Maneesha Mehra's co-authors include Ravi Potluri, Mary B. Todd, Howard I. Scher, Avinash Desai, Jan Schadrack, Saad Z. Usmani, Annette Lam, Nicole Cossrow, Nikhil C. Munshi and Jessica Vermeulen and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Maneesha Mehra

36 papers receiving 962 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Maneesha Mehra United States	14	348	286	277	239	199	37	985
Alby Elias United States	19	522 1.5×	123 0.4×	350 1.3×	213 0.9×	84 0.4×	38	1.2k
Ulrike Haus Germany	18	269 0.8×	99 0.3×	177 0.6×	216 0.9×	119 0.6×	31	955
J.L. Misset France	13	357 1.0×	119 0.4×	124 0.4×	121 0.5×	39 0.2×	39	733
Lois Brafman United States	11	832 2.4×	65 0.2×	159 0.6×	88 0.4×	76 0.4×	22	1.2k
Raj Tummala United States	25	507 1.5×	129 0.5×	70 0.3×	279 1.2×	180 0.9×	79	2.8k
Ronald Yanagihara United States	13	1.2k 3.5×	75 0.3×	584 2.1×	140 0.6×	269 1.4×	17	1.7k
Danielle Awad United States	11	829 2.4×	180 0.6×	136 0.5×	155 0.6×	66 0.3×	22	1.2k
Nguyet Le‐Lindqwister United States	16	1.1k 3.3×	299 1.0×	217 0.8×	153 0.6×	77 0.4×	29	1.6k
L. Robert Hill United States	21	411 1.2×	110 0.4×	138 0.5×	150 0.6×	38 0.2×	35	1.6k
H. Tzvi Thaler United States	10	189 0.5×	87 0.3×	136 0.5×	100 0.4×	115 0.6×	13	738

Countries citing papers authored by Maneesha Mehra

Since Specialization

Citations

This map shows the geographic impact of Maneesha Mehra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maneesha Mehra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maneesha Mehra more than expected).

Fields of papers citing papers by Maneesha Mehra

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maneesha Mehra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maneesha Mehra. The network helps show where Maneesha Mehra may publish in the future.

Co-authorship network of co-authors of Maneesha Mehra

This figure shows the co-authorship network connecting the top 25 collaborators of Maneesha Mehra. A scholar is included among the top collaborators of Maneesha Mehra based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maneesha Mehra. Maneesha Mehra is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Martin, Thomas, Amrita Krishnan, Kwee Yong, et al.. (2021). Comparison of outcomes with ciltacabtagene autoleucel (cilta-cel) in CARTITUDE-1 versus real-world standard of care (RW SOC) for patients (pts) with triple-class exposed relapsed/refractory multiple myeloma (RRMM).. Journal of Clinical Oncology. 39(15_suppl). 8045–8045. 5 indexed citations

He, Jianming, Rian Van Rampelbergh, Lugui Qiu, et al.. (2020). Treatment Pattern and Outcomes in Newly Diagnosed Multiple Myeloma Patients Who Did Not Receive Autologous Stem Cell Transplantation: A Real-World Observational Study. Advances in Therapy. 38(1). 640–659. 8 indexed citations

Fonseca, Rafaël, Saad Z. Usmani, Maneesha Mehra, et al.. (2020). Frontline treatment patterns and attrition rates by subsequent lines of therapy in patients with newly diagnosed multiple myeloma. BMC Cancer. 20(1). 1087–1087. 67 indexed citations

Smith, Matthew R., et al.. (2019). Relationship Between Metastasis-free Survival and Overall Survival in Patients With Nonmetastatic Castration-resistant Prostate Cancer. Clinical Genitourinary Cancer. 18(2). e180–e189. 15 indexed citations

Aly, Markus, Mahmoud Hashim, Bart Heeg, et al.. (2018). Time-to-event Outcomes in Men with Nonmetastatic Castrate-resistant Prostate Cancer—A Systematic Literature Review and Pooling of Individual Participant Data. European Urology Focus. 5(5). 788–798. 6 indexed citations

Chari, Ajai, et al.. (2018). Evaluation and Comparison of Characteristics and Outcomes Among Frontline Multiple Myeloma (FLMM) Patients with and without Stem Cell Transplant Treatment. Blood. 132(Supplement 1). 4738–4738. 1 indexed citations

Mehra, Maneesha, et al.. (2017). Utilization of Hypomethylating Agents and Associated Outcomes in Elderly Acute Myeloid Leukemia (AML) Patients: A Population Based Study. Blood. 130. 2157–2157. 5 indexed citations

Flaig, Thomas W., et al.. (2016). Disease and Treatment Characteristics of Men Diagnosed With Metastatic Hormone-Sensitive Prostate Cancer in Real Life: Analysis From a Commercial Claims Database. Clinical Genitourinary Cancer. 15(2). 273–279.e1. 9 indexed citations

Mato, Anthony R., Pengxiang Li, Maneesha Mehra, et al.. (2016). Characterization of Real World Treatment Patterns and Outcomes Among Older Adults with Chronic Lymphocytic Leukemia in the Pre Novel-Agents Era: An Analysis of the 2007-2013 SEER-Medicare Database. Blood. 128(22). 4773–4773. 1 indexed citations

10.

Mehra, Maneesha, et al.. (2016). Characterization of Disease, Treatment Patterns, and Outcomes of Patients with Myelofibrosis: Analysis of 2 United States Commercial Claims Databases. Blood. 128(22). 4769–4769. 2 indexed citations

11.

Mato, Anthony R., Pengxiang Li, Maneesha Mehra, et al.. (2016). Characterization of Real World Survival Outcomes Among Older Adults with Chronic Lymphocytic Leukemia Receiving Second Line Treatment in the Pre Novel-Agents Era: An Analysis of the 2007-2013 SEER-Medicare Database. Blood. 128(22). 4790–4790.

12.

Scher, Howard I., et al.. (2015). Prevalence of Prostate Cancer Clinical States and Mortality in the United States: Estimates Using a Dynamic Progression Model. PLoS ONE. 10(10). e0139440–e0139440. 176 indexed citations

13.

Maes, Edith, et al.. (2014). Pharmaceutical Portfolio Management: Global Disease Burden and Corporate Performance Metrics. Value in Health. 17(6). 732–738. 7 indexed citations

14.

Mehra, Maneesha, Sanjay Merchant, Shikha Gupta, & Ravi Potluri. (2014). Diabetic peripheral neuropathy: resource utilization and burden of illness. Journal of Medical Economics. 17(9). 637–645. 29 indexed citations

15.

Munshi, Nikhil C., Maneesha Mehra, Helgi van de Velde, et al.. (2014). Use of a claims database to characterize and estimate the incidence rate for Castleman disease. Leukemia & lymphoma. 56(5). 1252–1260. 105 indexed citations

16.

Mehra, Maneesha, et al.. (2013). Characterization of Treatment Resistant Depression Episodes in a Cohort of Patients from a US Commercial Claims Database. PLoS ONE. 8(10). e76882–e76882. 117 indexed citations

17.

Mehra, Maneesha, Ying Wu, & Ravinder Dhawan. (2012). Healthcare resource use in advanced prostate cancer patients treated with docetaxel. Journal of Medical Economics. 15(5). 836–843. 16 indexed citations

18.

Mehra, Maneesha, et al.. (2012). Use of a Claims Database to Characterize and Estimate the Incidence of Castleman's Disease. Blood. 120(21). 4253–4253. 9 indexed citations

19.

Mehra, Maneesha, Julia DiBello, Alan C. Fisher, & Roger M. Mills. (2011). Impact of relative contraindications on the use, benefits, and risks of anticoagulant prophylaxis in atrial fibrillation: analysis of a claims database. 1(3). 60–67. 4 indexed citations

20.

Mehra, Maneesha, et al.. (2011). The burden of chronic low back pain with and without a neuropathic component: a healthcare resource use and cost analysis. Journal of Medical Economics. 15(2). 245–252. 108 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact